<DOC>
	<DOC>NCT00264680</DOC>
	<brief_summary>Validation of qolie-10, an epilepsy specific quality of life questionnaire in patients treated with lamotrigine or valproic acid. Comparison of quality of life of epileptic patients treated with lamotrigine or valproic acid. Determination and assessment of the comparative safety of lamotrigine or valproic acid. Assessment and comparison of body image perception in women treated with lamotrigine or valproic acid.</brief_summary>
	<brief_title>Spanish Validation Of Quality of Life Questionnaire (QOLIE-10) For Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>Inclusion criteria: Diagnosis of epilepsy and normal neurological examination. Patients receiving lamotrigine or valproic acid at stable doses in monotherapy initiated 2 4 months before. Exclusion criteria: Pregnant or lactating women. Previous treatment with lamotrigine or valproic acid. Secondary epilepsy.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Validation of questionnaire</keyword>
	<keyword>qolie-10</keyword>
	<keyword>epilepsy</keyword>
	<keyword>lamotrigine</keyword>
	<keyword>quality of life</keyword>
</DOC>